Publications scientifiques

2023

Moritz CP, Tholance Y, Vallayer PB, Do LD, Muñiz-Castrillo S, Rogemond V, Ferraud K, La Marca C, Honnorat J, Killian M, Paul S, Camdessanché JP, Antoine JC. Anti-AGO1 Antibodies Identify a Subset of Autoimmune Sensory Neuronopathy. Neurol Neuroimmunol Neuroinflamm. 2023 Apr 18;10(3):e200105. doi: 10.1212/NXI.0000000000200105. PMID: 37072227; PMCID: PMC10112859.

2022

Moritz CP, Do LD, Tholance Y, Vallayer PB, Rogemond V, Joubert B, Ferraud K, La Marca C, Camdessanché JP, Honnorat J, Antoine JC. Conformation-stabilizing ELISA and cell-based assays reveal patient subgroups targeting three different epitopes of AGO1 antibodies. Front Immunol. 2022 Oct 20;13:972161. doi: 10.3389/fimmu.2022.972161. PMID: 36341350; PMCID: PMC9630334.

2021

Tholance Y, Antoine JC, Mohr L, Jung M, Reynaud-Federspiel E, Ferraud K, Camdessanché JP, Moritz CP. Anti-FGFR3 antibody epitopes are functional sites and correlate with the neuropathy pattern. J Neuroimmunol. 2021 Dec 15;361:577757. doi: 10.1016/j.jneuroim.2021.577757. Epub 2021 Oct 30. PMID: 34768040.

Do LD, Moritz CP, Muñiz-Castrillo S, Pinto AL, Tholance Y, Brugiere S, Couté Y, Stoevesandt O, Taussig MJ, Rogemond V, Vogrig A, Joubert B, Ferraud K, Camdessanché JP, Antoine JC, Honnorat J. Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases. Neurol Neuroimmunol Neuroinflamm. 2021 Jul 28;8(5):e1032. doi: 10.1212/NXI.0000000000001032. PMID: 34321331; PMCID: PMC8362341.

Moritz CP, Tholance Y, Stoevesandt O, Ferraud K, Camdessanché JP, Antoine JC. CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach. Neurol Neuroimmunol Neuroinflamm. 2021 Jan 6;8(2):e944. doi: 10.1212/NXI.0000000000000944. PMID: 33408168; PMCID: PMC7862091.

Moritz CP, Stoevesandt O, Tholance Y, Camdessanché JP, Antoine JC. Proper definition of the set of autoantibody-targeted antigens relies on appropriate reference group selection. N Biotechnol. 2021 Jan 25;60:168-172. doi: 10.1016/j.nbt.2020.08.007. Epub 2020 Oct 9. PMID: 33045420.

2020

Tholance Y, Moritz CP, Camdessanché JP, Antoine JC. What is the pattern of the neuropathy associated with anti-FGFR3 antibodies? Eur J Neurol. 2020 Oct;27(10):e58. doi: 10.1111/ene.14376. Epub 2020 Jul 1. PMID: 32498117.

Moritz CP. 40 years Western blotting: A scientific birthday toast. J Proteomics. 2020, 2020 Feb 10;212:103575. doi: 10.1016/j.jprot.2019.103575. PMID: 31706026

Moritz CP, Paul S, Stoevesandt O, Tholance Y, Camdessanché JP, Antoine JC. Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases. Autoimmun Rev. 2020 Feb;19(2):102450. doi: 10.1016/j.autrev.2019.102450. Epub 2019 Dec 12. PMID: 31838165.

2019

Tholance Y, Moritz CP, Rosier C, Ferraud K, Lassablière F, Reynaud-Federspiel E, França MC Jr, Martinez ARM, Camdessanché JP, Antoine JC; anti-FGFR3 antibody Study Group. Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies. J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):49-57. doi: 10.1136/jnnp-2019-321849. Epub 2019 Nov 5. PMID: 31690697.

Moritz CP, Tholance Y, Rosier C, Reynaud-Federspiel E, Svahn J, Camdessanché JP, Antoine JC. Completing the Immunological Fingerprint by Refractory Proteins: Autoantibody Screening via an Improved Immunoblotting Technique. Proteomics Clin Appl. 2019 Jul;13(4):e1800157. doi: 10.1002/prca.201800157. Epub 2019 Mar 4. PMID: 30768763.

Moritz CP, Tholance Y, Lassablière F, Camdessanché JP, Antoine JC. Reducing the risk of misdiagnosis of indirect ELISA by normalizing serum-specific background noise: The example of detecting anti-FGFR3 autoantibodies. J Immunol Methods. 2019 Mar;466:52-56. doi: 10.1016/j.jim.2019.01.004. Epub 2019 Jan 14. PMID: 30654043.

2017

Moritz CP. Tubulin or Not Tubulin: Heading Toward Total Protein Staining as Loading Control in Western Blots. Proteomics. 2017 Oct;17(20). doi: 10.1002/pmic.201600189. PMID: 28941183

2015

Antoine JC, Boutahar N, Lassablière F, Reynaud E, Ferraud K, Rogemond V, Paul S, Honnorat J, Camdessanché JP. Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy. J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1347-55. doi: 10.1136/jnnp-2014-309730. Epub 2015 Jan 27. PMID: 25628376.

Antoine JC, Robert-Varvat F, Maisonobe T, Créange A, Franques J, Mathis S, Delmont E, Kuntzer T, Lefaucheur JP, Pouget J, Viala K, Desnuelle C, Echaniz-Laguna A, Rotolo F, Camdessanché JP; French Neuromuscular Network FILNEMUS. Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies. J Neurol Sci. 2016 Feb 15;361:187-91. doi: 10.1016/j.jns.2015.12.044. Epub 2015 Dec 29. PMID: 26810539.

2014

Svahn J, Antoine JC, Camdessanché JP. Pathophysiology and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathies. Rev Neurol (Paris). 2014 Dec;170(12):808-17. doi: 10.1016/j.neurol.2014.10.009. Epub 2014 Nov 6. PMID: 25459126.

Antoine JC, Robert-Varvat F, Maisonobe T, Créange A, Franques J, Mathis S, Delmont E, Kuntzer T, Lefaucheur JP, Pouget J, Viala K, Desnuelle C, Echaniz-Laguna A, Rotolo F, Camdessanché JP; French CIDP study group. Testing the validity of a set of diagnostic criteria for sensory neuronopathies: a francophone collaborative study. J Neurol. 2014 Nov;261(11):2093-100. doi: 10.1007/s00415-014-7423-7. Epub 2014 Aug 10. PMID: 25108558.

2012

Camdessanché JP, Jousserand G, Franques J, Pouget J, Delmont E, Créange A, Kuntzer T, Maisonobe T, Abba K, Antoine JC; French CIDP study group. A clinical pattern-based etiological diagnostic strategy for sensory neuronopathies: a French collaborative study. J Peripher Nerv Syst. 2012 Sep;17(3):331-40. doi: 10.1111/j.1529-8027.2012.00411.x. PMID: 22971095.

Camdessanché JP, Ferraud K, Boutahar N, Lassablière F, Mutter M, Touret M, Kolattukudy P, Honnorat J, Antoine JC. The collapsin response mediator protein 5 onconeural protein is expressed in Schwann cells under axonal signals and regulates axon-Schwann cell interactions. J Neuropathol Exp Neurol. 2012 Apr;71(4):298-311. doi: 10.1097/NEN.0b013e31824d1df2. PMID: 22437341.

2011

Veyrac A, Reibel S, Sacquet J, Mutin M, Camdessanche JP, Kolattukudy P, Honnorat J, Jourdan F. CRMP5 regulates generation and survival of newborn neurons in olfactory and hippocampal neurogenic areas of the adult mouse brain. PLoS One. 2011;6(10):e23721. doi: 10.1371/journal.pone.0023721. Epub 2011 Oct 4. PMID: 21991301; PMCID: PMC3186791.

2009

Camdessanché JP, Jousserand G, Ferraud K, Vial C, Petiot P, Honnorat J, Antoine JC. The pattern and diagnostic criteria of sensory neuronopathy: a case-control study. Brain. 2009 Jul;132(Pt 7):1723-33. doi: 10.1093/brain/awp136. Epub 2009 Jun 8. PMID: 19506068; PMCID: PMC2702838.

Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V, Chapuis F, Aguera M, Decullier E, Duchemin AM, Graus F, Antoine JC. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):412-6. doi: 10.1136/jnnp.2007.138016. Epub 2008 Oct 17. PMID: 18931014; PMCID: PMC2664637.

2007

Antoine JC, Camdessanché JP. Peripheral nervous system involvement in patients with cancer. Lancet Neurol. 2007 Jan;6(1):75-86. doi: 10.1016/S1474-4422(06)70679-2. Erratum in: Lancet Neurol. 2007 May;6(5):389. PMID: 17166804.

2006

Camdessanché JP, Lassablière F, Meyronnet D, Férraud K, Absi L, Honnorat J, Antoine JC. Expression of the onconeural CV2/CRMP5 antigen in thymus and thymoma. J Neuroimmunol. 2006 May;174(1-2):168-73. doi: 10.1016/j.jneuroim.2006.01.018. Epub 2006 Mar 7. PMID: 16519949.

2002

Camdessanché JP, Antoine JC, Honnorat J, Vial C, Petiot P, Convers P, Michel D. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain. 2002 Jan;125(Pt1):166-75. doi: 10.1093/brain/awf006. PMID: 11834602.

2001

Antoine JC, Honnorat J, Camdessanché JP, Magistris M, Absi L, Mosnier JF, Petiot P, Kopp N, Michel D. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol. 2001 Feb;49(2):214-21. doi: 10.1002/1531-8249(20010201)49:2<214::aid-ana41>3.0.co;2-w. PMID: 11220741.